Mesothelioma

197P - Effect of surgical treatment on the survival in patients with malignant pleural mesothelioma

Authors
  • R. Baez-Saldana (Ciudad de México, Mexico)
  • M. Marmolejo-Torres (Mexico City, Mexico)
  • M. Iñiguez-García (Mexico City, Mexico)
  • J. Berrios Mejía (Mexico City, Mexico)
  • U. Rumbo-Nava (Mexico City, Mexico)
  • O. Arrieta-Rodríguez (Mexico City, Mexico)
Speakers
  • R. Baez-Saldana (Ciudad de México, Mexico)

Previous ePoster
141P - Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)

Next ePosters
59P - Comparison of internal target volume delineation using CT datasets of four-dimensional computed tomography in lung cancer radiotherapy
78P - Lung resection for cancer in patients with heart disease: Management and postoperative outcome
199P - Safety meta-analysis of clinical trials delivering TTFields to the upper torso
79P - Tissue microarray analysis on prognostic value of coexpression of RUNX3 and trimethylated histone H3 lysine 27 in surgically resected patients with stage I non-small cell lung cancer
180TiP - An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
No ePoster preview available
15P - TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor
No ePoster preview available
80P - High blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)
169P_PR - Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)
73P - Utilization rates of stereotactic body radiation therapy for the treatment of stage I NSCLC in three European countries
31P - Do two lungs form an integrated immune system? Learning from BALF examination in lung cancer